You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FLK-1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Identify Mechanisms of Menopause on Cardiovascular Disease Risk

Not yet recruiting
  • Menopause
  • +3 more
    • Copenhagen, Denmark
      Deparment of Nutrition, Exercise and Sports
    Dec 3, 2022

    Thrombosis, Menopause, Exercise Training Trial in Copenhagen (Early and late postmenopausal women)

    Active, not recruiting
    • Thrombosis
    • +3 more
    • Early and late postmenopausal women
    • Copenhagen, Denmark
      Ylva Hellsten
    Nov 1, 2022

    Nasopharyngeal Tumors Trial in China (Sintilimab, Gemcitabine, Cisplatin)

    Active, not recruiting
    • Nasopharyngeal Neoplasms
    • Foshan, Guangdong, China
    • +8 more
    Oct 6, 2022

    Pancreas Cancer, Ovarian Cancer, Melanoma Trial in Rozzano (Regorafenib)

    Completed
    • Pancreas Cancer
    • +6 more
    • Rozzano, Milan, Italy
      Istituto Clinico Humanitas
    Sep 9, 2022

    Post Covid-19 Hypoxia on Placenta of Normal Pregnant Women: A

    Not yet recruiting
    • Hif-1α Covid-19
    • HiF-1 alpha measurement
    • (no location specified)
    Dec 14, 2021

    Nasopharyngeal Carcinoma, Nutritional Support Trial in China (dietary supplement, radiation, drug)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Nutritional Support
    • Abbott®Ensure
    • +2 more
    • Fuzhou, Fujian, China
    • +12 more
    May 16, 2022

    Nasopharyngeal Carcinoma Trial in Guangzhou (MRI Scanning, Contrast-Enhanced Ultrasonography, Ultrasound-guided Lymph Node

    Recruiting
    • Nasopharyngeal Carcinoma
    • MRI Scanning
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-Sen University Cancer Center
    Jul 4, 2022

    Rheumatoid Arthritis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )

    Completed
    • Rheumatoid Arthritis
    • LNK01001 Dose A
    • +2 more
    • Beijing, China
      Peking Union Medical College Hospital
    Oct 24, 2023

    Ankylosing Spondylitis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, Placebo)

    Completed
    • Ankylosing Spondylitis
    • LNK01001 Dose A
    • +2 more
    • Beijing, China
      Peking Union Medical College Hospital
    Oct 10, 2023

    COVID-19 Trial in Thái Bình (COVIVAC vaccine)

    Completed
    • COVID-19
    • COVIVAC vaccine
    • Thái Bình, Thai Binh, Vietnam
      District Health Center of Vu Thu District
    Jul 12, 2023

    Relapsing Remitting Multiple Sclerosis Trial (PIPE-307 Dose A, PIPE-307 Dose B, Placebo)

    Not yet recruiting
    • Relapsing Remitting Multiple Sclerosis
    • PIPE-307 Dose A
    • +2 more
    • (no location specified)
    Oct 9, 2023

    Meningococcal Meningitis Trial in Surabaya (batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4), batch 2 of

    Not yet recruiting
    • Meningococcal Meningitis
    • batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4)
    • +3 more
    • Surabaya, Indonesia
      Husada Utama Hospital
    Nov 13, 2023

    Atopic Dermatitis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )

    Completed
    • Atopic Dermatitis
    • LNK01001 Dose A
    • +2 more
    • Beijing, China
      Jianzhong Zhang
    Oct 10, 2023

    Hypertension,Essential Trial in China (Songling Xuemaikang Capsules, Lifestyle intervention, Placebo)

    Not yet recruiting
    • Hypertension,Essential
    • Songling Xuemaikang Capsules
    • +2 more
    • Beijing, Beijing, China
    • +4 more
    Oct 17, 2023

    Hepatocellular Carcinoma Trial in Beijing (iNKT Cells, PD-1, Regorafenib)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • iNKT Cells
    • +2 more
    • Beijing, Beijing, China
      Beijing Youan Hospital,Capital Medical University
    Jul 24, 2023

    SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)

    Completed
    Has Results
    • SARS-CoV-2 Infection
    • COVID-19
    • BNT162b2
    • +2 more
    • Brookvale, New South Wales, Australia
    • +25 more
    Nov 22, 2023

    Type1diabetes, Hypoglycemia, Type 1 Diabetes Trial in Hellerup (Infusion of GIP[1-42], GIP[1-30] or )

    Recruiting
    • Type1diabetes
    • +2 more
    • Infusion of GIP[1-42], GIP[1-30] or placebo
    • Hellerup, Copenhagen, Denmark
      Center for Clinical Metabolic Research, Gentofte Hospital
    Nov 17, 2023

    SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)

    Completed
    • SARS-CoV-2 Infection
    • COVID-19
    • BNT162b2
    • +2 more
    • Brookvale, New South Wales, Australia
    • +25 more
    Nov 13, 2023

    COVID-19 Trial (STI-1558)

    Not yet recruiting
    • COVID-19
    • (no location specified)
    Sep 15, 2023

    Diabetes Trial (INS062 injection?INS068 injection?HR20014 injection)

    Not yet recruiting
    • Diabetes
    • INS062 injection、INS068 injection、HR20014 injection
    • (no location specified)
    May 24, 2023

    Serum Retinoic Acid Induced Protein 14 and Metastasis Associated

    Not yet recruiting
    • Breast Cancer
    • laboratory test (RAI14 and MACC-1 )
    • (no location specified)
    Oct 18, 2023

    Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (BEAM-201)

    Recruiting
    • Lymphoblastic Lymphoma
    • +2 more
    • BEAM-201
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Jun 2, 2023

    Tetanus Trial in Bijie (TTVA, TT)

    Not yet recruiting
    • Tetanus
    • TTVA
    • TT
    • Bijie, Guizhou, China
      Center for Disease Control and Prevention, Qixingguan District,
    Nov 7, 2023

    Tetanus Trial in Bijie (TTVA, TT)

    Not yet recruiting
    • Tetanus
    • TTVA
    • TT
    • Bijie, Guizhou, China
      Center for Disease Control and Prevention, Qixingguan District,
    Nov 7, 2023

    Healthy Women of Child Bearing Potential Trial (R21/Matrix-M1, Saline and R21/Matrix-M1, Sterile isotonic (0.9%) normal saline)

    Not yet recruiting
    • Healthy Women of Child Bearing Potential
    • R21/Matrix-M1
    • +2 more
    • (no location specified)
    Oct 10, 2023